Dana Miskulin, MD
Enriched profileAssociate Professor of Medicine, Tufts University School of Medicine · Tufts Medical Center
Dana Miskulin is Associate Professor of Medicine, Tufts University School of Medicine at Tufts Medical Center. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 2 Sept 2026
Dana C. Miskulin, MD, is Associate Professor of Medicine, Tufts University School of Medicine at Tufts Medical Center, Division of Nephrology, Boston, MA. The public record shows 150 publications with 6,840 citations (h-index 47), centered on ESRD / Dialysis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 3 companies, 1 NIH-funded awards (2004–2008).
- Top research focus: ESRD / Dialysis
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 2 Sept 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Bempedoic Acid Therapy for Polycystic Kidney Disease
Sponsor: Kenneth Hallows
- Dialysate Sodium Lowering Trial
Sponsor: Tufts Medical Center
- Blood Pressure in Dialysis Patients
Sponsor: University of New Mexico
Industry payments
Updated 2 Sept 2026
3 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Vantive US Healthcare LLCProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20244 payments
- Travere Therapeutics, Inc.Program year20245 payments
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.8%Angiotensin receptor blocker (ARB)23.4%Losartan Potassium100%Part D<11 patientsBeta blocker20.3%Metoprolol Tartrate100%Part D<11 patientsGenitourinary & hormones
17.2%Reducing and Complexing Thiol17.2%Thiola Ec100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 2 Sept 2026
1 NIH research award on record, funded 2004–2008 per NIH RePORTER. The latest:
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis
American Journal of Kidney Diseases
2022 - COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider
American Journal of Kidney Diseases
2021 - Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review
American Journal of Kidney Diseases
2020
Online presence
Updated 2 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/dana-miskulin-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Dana-Miskulin-38189551
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Other
facultyprofiles.tufts.edu/dana-miskulin
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facultyprofiles.tufts.edu ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/asnpublications/status/1311682088328929285
- X / Twitter
Announcement of CJASN Associate Editor appointment, posted by official ASN Publications account (@asnpublications)
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 2 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
- Board Certified
American Board of Internal Medicine - Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Board Certified
American Board of Internal Medicine - Nephrology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
Editorial Leadership Team, Clinical Journal of the American Society of Nephrology (CJASN) -- since October 2020
2020 - Attending Nephrologist
Division of Nephrology, Tufts Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tuftsmedicine.org ↗
Secondary affiliations
appointments beyond the home institution- Dialysis Clinic
Inc. (DCI) -- receives salary support from DCI (paid relationship, not an academic appointment)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Levey, MD
Tufts Medical Center
Mark Sarnak, MD
Tufts Medical Center
James Udelson, MD
Tufts Medical Center
Nicholas Hill, MD
Tufts Medical Center